Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2014

View Archived Issues

Clinical study evaluates immunological response EMD-640744 in solid tumors

Shandong Xuanzhu Pharmaceutical Technology patents novel inhibitors for cancer

Mitsubishi Tanabe Pharma discloses new TRPM8 agonists for chronic pain

Meda and Valeant terminate joint ventures in Canada, Mexico and Australia

Santen and Oak Pharmaceuticals sign U.S. tafluprost licensing agreement

Pharmacokinetic bioequivalence of biosimilar GP-2017 and reference adalimumab

Lilly and Deciphera Pharmaceuticals present data on LY-3009120

Aptiom launched in the U.S. for use as adjunctive treatment of partial-onset seizures

Novel dendrimer-drug conjugates patented by Indian university

Mersana Therapeutics and Takeda to develop next-generation antibody-drug conjugates

IGM-55.5 potently binds and kills B cells in NHL patients

Soligenix receives SBIR grant award supporting phase II trial of SGX-942

JNJ-61186372 demonstrates activity for the treatment EGFR/c-Met-aberrant malignancies

Genentech and Array BioPharma reports ERK-1/2 inhibitor, GDC-0994

Abbott and AbbVie disclose new PDE10A inhibitors

Roche and Oryzon to develop epigenetics-based medicines

Pradaxa approved for deep venous thrombosis and pulmonary embolism

Merck & Co., Ferring and WHO to study room temperature-stable carbetocin for post-partum hemorrhage

Daiichi Sankyo extends European PREFER in AF registry

Cancer Genetics launches CALR mutation analysis test

Arno Therapeutics enrolls first patient in phase I/II onapristone trial in prostate cancer

Bristol-Myers Squibb submits daclatasvir and asunaprevir NDAs to FDA for HCV

Sun Pharmaceutical to acquire Ranbaxy Laboratories from Daiichi Sankyo

RedHill Biopharma to submit European MAA for RHB-102

Xenetic Biosciences reports phase I data for PulmoXen in cystic fibrosis

OncoSec Medical to relaunch phase II CTCL trial of ImmunoPulse DNA IL-12

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...